Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 14, Issue 10

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Drug Safety, Volume 14, Issue 10 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 10 (2015)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Risk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis

Omar Abdel-Rahman & Hesham ElHalawani

Pages: 1495-1506

Published online: 26 Aug 2015

AbstractforRisk of oral and gastrointestinal mucosal injury in patients with solid tumors treated with ramucirumab: a systematic review and meta-analysis | Full Text | References | PDF (768.8 KB)

410 Views
6 CrossRef citations
0Altmetric

Article

Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Omar Abdel-Rahman (Faculty of Medicine) , Hesham ElHalawani (Faculty of Medicine) & Mona Fouad (Faculty of Medicine)

Pages: 1507-1518

Published online: 07 Sep 2015

AbstractforRisk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis | Full Text | References | PDF (665.4 KB)

611 Views
42 CrossRef citations
0Altmetric

Review

Risk-adapted strategies for the treatment of Hodgkin lymphoma

Jesse Keller & Kenneth R Carson

Pages: 1519-1530

Published online: 22 Sep 2015

AbstractforRisk-adapted strategies for the treatment of Hodgkin lymphoma | Full Text | References | PDF (291.7 KB)

185 Views
2 CrossRef citations
0Altmetric

The safety of calcineurin inhibitors for kidney-transplant patients

Paolo Malvezzi MD & Lionel Rostaing MD, PhD

Pages: 1531-1546

Published online: 25 Aug 2015

AbstractforThe safety of calcineurin inhibitors for kidney-transplant patients | Full Text | References | PDF (368.7 KB)

1356 Views
57 CrossRef citations
0Altmetric

Do statins prevent acute kidney injury?

Barbara Philips (Reader in Intensive Care Medicine) & Iain MacPhee (Reader in Renal Medicine)

Pages: 1547-1561

Published online: 12 Sep 2015

AbstractforDo statins prevent acute kidney injury? | Full Text | References | PDF (362.9 KB)

380 Views
6 CrossRef citations
0Altmetric

Foetal safety of old and new antiepileptic drugs

Alberto Verrotti, Elisabetta Mencaroni, Miriam Castagnino & Gaetano Zaccara

Pages: 1563-1571

Published online: 25 Aug 2015

AbstractforFoetal safety of old and new antiepileptic drugs | Full Text | References | PDF (256.3 KB)

781 Views
10 CrossRef citations
0Altmetric

Metformin: risk-benefit profile with a focus on cancer

Nicoletta Provinciali, Matteo Lazzeroni, Massimiliano Cazzaniga, Franco Gorlero, Barbara K Dunn & Andrea DeCensi

Pages: 1573-1585

Published online: 11 Sep 2015

AbstractforMetformin: risk-benefit profile with a focus on cancer | Full Text | References | PDF (642.2 KB)

519 Views
16 CrossRef citations
0Altmetric

Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis

Britta Galling MD, Amat Calsina Ferrer MD, Margarita Abi Zeid Daou MD, Dinesh Sangroula MD, Katsuhiko Hagi PhD & Christoph U Correll MD

Pages: 1587-1608

Published online: 10 Sep 2015

AbstractforSafety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis | Full Text | References | PDF (467 KB)

792 Views
14 CrossRef citations
0Altmetric

Safety of anticonvulsant agents in pregnancy

Hind N Moussa MD, Alejandra Elder Ontiveros MD, Ziad A Haidar MD & Baha M Sibai MD

Pages: 1609-1620

Published online: 01 Sep 2015

AbstractforSafety of anticonvulsant agents in pregnancy | Full Text | References | PDF (349.4 KB)

581 Views
3 CrossRef citations
0Altmetric

Drug Safety Evaluation

The clinical safety of ibrutinib in chronic lymphocytic leukemia

Stefano Molica MD

Pages: 1621-1629

Published online: 11 Sep 2015

AbstractforThe clinical safety of ibrutinib in chronic lymphocytic leukemia | Full Text | References | PDF (396.2 KB)

977 Views
6 CrossRef citations
0Altmetric

Asunaprevir for hepatitis C: a safety evaluation

Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Riccardo Scotto & Guglielmo Borgia

Pages: 1631-1646

Published online: 31 Aug 2015

AbstractforAsunaprevir for hepatitis C: a safety evaluation | Full Text | References | PDF (331.4 KB)

233 Views
5 CrossRef citations
0Altmetric

Retraction

Page: 1647

Published online: 22 Sep 2015

CitationforRetraction | Full Text | PDF (41.3 KB)

1109 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Zhou Zhu et al.

Article | Published online: 17 May 2024

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study

Haiying Ding et al.

Review Article | Published online: 16 May 2024

Adverse tumor events induced by Ranitidine: an analysis based on the FAERS Database

Tian Liu et al.

Article | Published online: 16 May 2024

Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Guixiang Chen et al.

Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.14, Iss.10, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?